The mechanism
Neuroinflammation, neurotrophic support, and cognitive decline
Cognitive decline and dementias like Alzheimer's are increasingly understood to involve chronic neuroinflammation and the progressive loss of the neurotrophic support that keeps neurons alive and connected. These are the same biological pathways that ibogaine acts on.
Ibogaine reduces pro-inflammatory cytokines including TNF-alpha and IL-6, upregulates GDNF (a protein central to neuronal survival), and increases neuroplasticity, the brain's capacity to form and strengthen neural connections. In principle, these mechanisms are relevant to the biology of cognitive decline.
In practice, this is an emerging and complementary approach, not an established treatment proven in large clinical trials. We say that plainly. What we offer is a medically supervised, mechanism-based program aimed at supporting neural health, alongside conventional care, for those for whom it is appropriate.
Please read this carefully
What we do, and do not, promise
We do not claim to cure, reverse, or stop dementia. No ethical clinic can, and any program that promises to reverse dementia should be treated with real caution, especially when a family is frightened and hopeful.
This approach is best considered for early cognitive decline and mild cognitive impairment, where the person can fully understand and consent to treatment for themselves. Our medical team assesses candidacy carefully, and for many people, and many stages, our answer will honestly be that this program is not appropriate.
If we cannot help someone safely and honestly, we will tell you so. That candor is the most important thing we offer families facing cognitive decline.
The approach
How the program supports neural health
Anti-Inflammatory Action
Reduction of the pro-inflammatory cytokines (TNF-α, IL-6) increasingly implicated in the neuroinflammatory component of cognitive decline.
GDNF Neurotrophic Support
Upregulation of Glial Cell-Derived Neurotrophic Factor, a protein central to the survival and maintenance of neurons.
Neuroplasticity
Support for the brain's capacity to form new connections, the basis of cognitive reserve and compensation.
Careful Candidacy Screening
A thorough assessment of disease stage, capacity to consent, cardiac health, and appropriateness. Not everyone is a candidate, and we say so honestly.
Family Involvement
We involve the people who love and care for the person, and we keep expectations realistic and grounded throughout.
Measured, Not Assumed
Cognitive and wellbeing baselines are captured and re-measured, so any change is tracked honestly rather than hoped for.
The process
A careful, screened program
Candidacy & medical screening
Before anything else, our medical team reviews disease stage, capacity to consent, cardiac health, and whether the program is safe and appropriate. For many, the honest answer is no.
Neurotrophic priming
For appropriate candidates, an extended anti-inflammatory and neurotrophic protocol under medical supervision.
Supervised session
The medically supervised session under continuous cardiac monitoring.
Integration & honest measurement
Structured integration and cognitive/wellbeing re-measurement against baseline, with realistic, family-involved follow-up.
Primary References
Our protocols align with the primary scientific literature, including the MAPS Ibogaine Investigator's Brochure (July 2026), NIDA's psychedelic & dissociative drugs research, and registered trials on ClinicalTrials.gov. Ibogaine remains investigational; we pair published evidence with measured, real-world outcome tracking.
Measured & safe
Recovery you can track. Safety you can trust.
Our proprietary data system measures your progress before, during, and after your stay, and monitors your safety at every step. The same data that keeps you safe is the data that proves it worked.
Validated instruments build your baseline before you travel.
Cardiac and vital monitoring around your session, read in real time.
Your progress re-scored against your baseline, in your portal.
Every MindScape treatment program includes a guided 5-MeO-DMT (Bufo) ceremony — part of the all-inclusive price, not an add-on.
Questions
Dementia treatment, answered honestly
Precision dosing
Your main dose is measured, not estimated
Before the main session, we give a short series of low, sub-psychoactive ibogaine TA boosters. Each one is a measurement. Ibogaine and its long-lived metabolite noribogaine both affect the heart's hERG potassium channel, and that effect is dose-dependent, so instead of predicting how you will respond we observe it directly at doses far below a full session. Your main dose is then chosen from your own cardiac response and the margin you have left.
No ibogaine given. 12-lead ECG, electrolytes and liver panel establish the starting point. A baseline outside safe limits stops the programme here.
These are the measurements the protocol is built around. The trace above is a schematic used to explain the method; it is not a recording of a patient, and the values shown are illustrative rather than results.
How the booster protocol works for dementia →Related neurological programs: Neurodegenerative overview · ALS & motor neuron disease · Huntington's disease · Parkinson's disease · Multiple sclerosis
Looking for ibogaine treatment for dementia and cognitive decline accessible from your state? MindScape Retreat treats patients from across the US with direct flights to Cozumel. Find ibogaine treatment near you.